ERic Acute StrokE Recanalization: A study using predictive analytics to assess a new device for mechanical...

Area of Science:

• Neuroscience
• Interventional Neurology
• Medical Technology

Background:

• Acute ischemic stroke is a leading cause of disability.
• Mechanical thrombectomy is a critical treatment for large vessel occlusions.
• Existing treatments like intravenous tissue plasminogen activator have limitations.

Purpose of the Study:

• To evaluate the effectiveness of next-generation mechanical thrombectomy devices.
• To compare this new methodology against intravenous tissue plasminogen activator therapy alone.
• To introduce a novel study design utilizing predictive analytics for stroke intervention evaluation.

Main Methods:

• Prospective, single-arm, multicenter, controlled, open-label study (ERic Acute StrokE Recanalization).
• Inclusion of acute ischemic stroke patients with internal or middle cerebral artery occlusion.
• Primary endpoint: volume of saved tissue, calculated using a machine learning model trained on historical IV tissue plasminogen activator data.

Main Results:

• The study aims to demonstrate efficacy greater than 38% for the new thrombectomy devices.
• A sample size of 45 patients is estimated for statistical significance.
• The study introduces predictive analytics as a primary and secondary endpoint in interventional stroke trials.

Conclusions:

• This study pioneers the use of predictive analytics in evaluating neurovascular interventions.
• While not a replacement for randomized controlled trials, this design offers a model for assessing non-pivotal interventions.
• Next-generation thrombectomy devices warrant further investigation for improving clinical outcomes in ischemic stroke.